Caprolactam Chemicals Ltd (CAPRO) — shareholding pattern, promoter holding, financials and share price
About Caprolactam Chemicals Ltd (CAPRO)
Caprolactam Chemicals Ltd operates in the Commodity Chemicals industry, within the Chemicals sector. It trades on the NSE as CAPRO and on the BSE under scrip code 507486. Its ISIN is INE470N01010.
Incorporated in 1992, Caprolactam Chemicals Ltd is in the business of chemical manufacturing and provides Job work services [1]
Caprolactam Chemicals Ltd specializes in chemical manufacturing and offers contract manufacturing services across various sectors such as flavors, fragrance, aroma, pharma, and agrochemicals.
Originally established as a sick company in 2001 due to financial challenges, Caprolactam Chemical's financial health improved gradually, enabling its exit from the sick company list by 2006.
Listed peers in Commodity Chemicals: Deco-Mica Ltd, Asian Petroproducts & Exports Ltd, Pentokey Organy (India) Ltd, Vinyoflex Ltd, Kobo Biotech Ltd, Advance Petrochemicals Ltd.
Valuation & Returns
At ₹47.5 a share, Caprolactam Chemicals Ltd (CAPRO) was valued at a price-to-earnings ratio of 13.45x against an industry P/E of 45.11x and a price-to-book of 3.6x on a book value of ₹14.3 per share. Solomo computes return on equity of 26.76% and return on capital employed of 18.25% from filed results.
- P/E
- 13.45x
- Industry P/E
- 45.11x
- P/B
- 3.6x
- EPS (TTM)
- ₹3.83
- Book value / share
- ₹14.3
- ROE
- 26.76%
- ROCE
- 18.25%
- ROA
- 10.39%
- Debt / equity
- 1.4x
- Dividend yield
- 0%
- EBITDA margin
- 42.65%
- 52-week range
- ₹38.1 – ₹81
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Caprolactam Chemicals Ltd (CAPRO) reported revenue of ₹10.56 crore, net profit of ₹1.76 crore and earnings per share of ₹3.83. That compares with revenue of ₹6.74 crore and net profit of ₹-0.71 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹3.07 crore and net profit ₹0.84 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 2.07 | 9.84 | 6.96 | 6.74 | 10.56 |
| Net profit (₹ cr) | -1.28 | 2.55 | 0.2 | -0.71 | 1.76 |
| EPS (₹) | -2.78 | 5.54 | 0.43 | -1.54 | 3.83 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 3.66% | 0.69% | 48.24% | -3.16% |
| Profit growth | - | - | - | -455.00% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 54.5% of Caprolactam Chemicals Ltd (CAPRO) (unchanged from the previous quarter). Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: LAXMIDAS V. BHANUSHALI 1.28%, ALIYA KHATUN 1.17%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 54.5% | - | - | - | 45.5% |
| Mar 2026 | 54.5% | - | - | - | 45.5% |
| Dec 2025 | 54.5% | - | - | - | 45.5% |
| Sep 2025 | 54.05% | - | - | - | 45.95% |
| Jun 2025 | 54.04% | - | - | - | 45.96% |
| Mar 2025 | 54.02% | - | - | - | 45.98% |
| Dec 2024 | 53.99% | - | - | - | 46.01% |
| Sep 2024 | 53.97% | - | - | - | 46.03% |